Showing results (1-10 of 588) with videos related to

Sort By:
Pageof 59
Gastroenterology|May 2, 2024
Risk of Cancers Proximal to the Colon in Fecal Immunochemical Test Positive Screenees in a Colorectal Cancer Screening ProgramWillemijn de Klaver, Manon van der Vlugt, Manon C W Spaander, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 30, 2019
A Quarter of Participants With Advanced Neoplasia Have Discordant Results From 2-Sample Fecal Immunochemical Tests for Colorectal Cancer ScreeningEls Wieten, Clasine M de Klerk, Iris Lansdorp-Vogelaar, et al.
Endoscopy|October 23, 2025
Individuals with polyps ≥10 mm without other high risk features have a similarly low post-colonoscopy colorectal cancer risk to those with no polypsNanette S van Roermund, Monique E van Leerdam, Manon C W Spaander, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 17, 2025
Rethinking Post-colonoscopy Colorectal Cancer Risk: Endoscopist Performance Versus Presence of High-risk PolypsNanette S van Roermund, Veerle M H Coupé, Manon C W Spaander, et al.
Alimentary Pharmacology & Therapeutics|April 10, 2025
Diagnostic Accuracy of an Add-On, Blood-Based Screening Test for Colorectal Cancer in Two Established Screening ProgrammesTim L Kortlever, Enea Ferlizza, Mattia Lauriola, et al.
Endoscopy|April 7, 2026
Prevalence and characteristics of sessile serrated lesions with dysplasia in Dutch fecal immunochemical test-positive screeneesNanette S van Roermund, Valentina Angerilli, Iris D Nagtegaal, et al.
The Lancet. Gastroenterology & Hepatology|October 21, 2023
Metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after extensive versus partial colectomy in the Netherlands: a retrospective cohort studyEllis L Eikenboom, Sarah Moen, Monique E van Leerdam, et al.
World Journal of Gastrointestinal Oncology|November 28, 2022
Missed colorectal cancers in a fecal immunochemical test-based screening program: Molecular profiling of interval carcinomasManon van der Vlugt, Beatriz Carvalho, Joelle Fliers, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 11, 2018
Risk of Oral and Upper Gastrointestinal Cancers in Persons With Positive Results From a Fecal Immunochemical Test in a Colorectal Cancer Screening ProgramManon van der Vlugt, Esmée J Grobbee, Patrick M Bossuyt, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 2021
Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the NetherlandsEsther Toes-Zoutendijk, Geraldine Vink, Iris D Nagtegaal, et al.
Pageof 59